本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kiora Pharmaceuticals

2.75
+0.09003.38%
成交量:1.10万
成交额:2.98万
市值:1,218.91万
市盈率:-1.14
高:2.75
开:2.65
低:2.65
收:2.66
52周最高:2.95
52周最低:1.76
股本:443.24万
流通股本:385.25万
量比:0.64
换手率:0.29%
股息:- -
股息率:- -
每股收益(TTM):-2.4100
每股收益(LYR):-2.6400
净资产收益率:-56.36%
总资产收益率:-21.92%
市净率:0.72
市盈率(LYR):-1.04

数据加载中...

2026/08/19

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/10

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/07

重要事件披露

Form 8-K - Current report
2026/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/06/18

重要事件披露

Form 8-K - Current report
2026/06/11

重要事件披露

Form 8-K - Current report
2026/05/21

SEC问询函

Form CORRESP - Correspondence
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

重要事件披露

Form 8-K - Current report
2026/04/07

重要事件披露

Form 8-K - Current report
2026/04/02

重要事件披露

Form 8-K - Current report
2026/03/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/25

重要事件披露

Form 8-K - Current report
2026/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/11/07

重要事件披露

Form 8-K - Current report